EMA: Waiving MD study [Regulatives / Guidelines]

posted by wienui  – Germany/Oman, 2020-09-09 17:43 (708 d 03:30 ago) – Posting: # 21913
Views: 2,590

Hi Helmut,

» at the end an [image] script to play with.
»
» For any elimination half life of > 7 hours and an intended dosing interval of 24 hours it will be impossible to get the MD study waived. Red are formulations with flip-flop PK (kakel).

Could you please kindly add more explanation.

Cheers,
Osama

Complete thread:

UA Flag
Activity
 Admin contact
22,305 posts in 4,668 threads, 1,587 registered users;
online 7 (0 registered, 7 guests [including 5 identified bots]).
Forum time: Thursday 21:13 CEST (Europe/Vienna)

On two occasions I have been asked,—“Pray, Mr. Babbage,
if you put into the machine wrong figures,…
will the right answers come out?”
 …
I am not able rightly to apprehend the kind of confusion of ideas
that could provoke such a question.    Charles Babbage

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5